In , Yatharth Hospital & Trauma Care Services Ltd (Hospitals) is outperforming Nifty 500 with +35.5% relative strength. Fundamentals: Average. On a 5-week streak.
Weekly presence in the outperformers list. Green = beating Nifty 500 by 10%+ that week.
Based on Q3 FY26 earnings • Updated Apr 18, 2026
What: Adjusted EBITDA Margin: 29.2%
“Adjusting for the initial ramp-up losses at our newly operationalized New Delhi and Faridabad Sector-20 hospitals, our adjusted EBITDA margin stood strong at 29.2%.”
What: Oncology Revenue Share: 10%
Impact: Targeting 15% share
“Oncology today is contributing close to 10% of our overall specialty pie... we expect oncology to touch around 15% in less than 2 years' time.”
What: Bed Capacity: 2,550 beds
“With the Agra addition, we would be around 2,550 beds. We feel that probably in the next 3 to 4 years, there is still scope in the company to even close to double this capacity.”
What: Revenue growth of 46% vs 30% guidance
“In the first full quarter of operations, these hospitals generated INR279 million in revenue, contributing 9% to group's revenues.”
What: 3,000 beds by 2028 → 5,000 beds
“we have revised our bed capacity target rather than now talking about 3,000 beds in '28, the bed capacity would be much more for next 3 years from today.”
Earnings deceleration risks from management commentary
Trigger: Changes in the definition of wages under the new codes may increase long-term employee benefit liabilities.
Management view: Management has already factored minor impacts into gratuity and perceives no major impact on bonuses or leave encashment.
Monitor: regulatory
Trigger: Increased competition in the territory as new brands enter the market.
Management view: Management believes territory development attracts more patients and they are prepared for doctor movement as 'part and parcel' of the industry.
Monitor: labor
Key quotes from recent conference calls
“Lastly, your question on the 30% revenue growth. Yes, I think that's easily visible. I think we are being actually a bit conservative when we're seeing 30% revenue growth. [Previous Revenue Growth guidance]”
“Also, for last 2, 3 years, clearly, we have shown 8% to 10% ARPOB growth. And I think for next 3 years also, we do expect 8% to 10% ARPOB growth clearly. [Previous ARPOB Growth guidance]”
“Agra Hospital... has had a revenue of close to INR45 crores to INR50 crores and is almost now EBITDA positive and P&L positive also. [Initiative: Agra Hospital Integration]”
“However, minor impact may come as a change of the basic pay, which has been factored to the gratuity. [Risk (regulatory): LOW]”
Headline numbers from the latest earnings call
Revenue
₹3,205 million
Why: Growth was driven by a 33% year-over-year increase in existing hospitals and the first full quarter of operations from new facilities in New Delhi and Faridabad.
The company achieved its highest-ever quarterly revenue, significantly aided by the rapid scale-up of newly operational units.
EBITDA
₹742 million
Why: Profitability was driven by operating leverage and mix improvement, despite initial ramp-up losses at newly operationalized hospitals.
Adjusted EBITDA margins reached 29.2% when excluding the drag from the newest facilities.
PAT
₹431 million
Why: Net profit growth was supported by the positive impact of price revisions in government business and improved operational efficiencies.
Adjusted PAT growth of 80% highlights the underlying profitability of the mature hospital portfolio.
Other Highlights
• New Delhi and Faridabad Sector-20 hospitals contributed 9% to group revenues in their first full quarter.
• Noida Extension hospital achieved its highest-ever ARPOB of approximately ₹44,000.
• Agra hospital was fully integrated into the network effective February 1, 2026.
Sub-sector-specific signals from the latest concall — each with management's stated reason for the change
ARPOB (Consolidated)
₹33,744
Why: Driven by improved case mix and higher contribution from super-specialty services like oncology.
Overall Occupancy
67%
Why: Maintained healthy levels despite the addition of 700 new beds in the previous quarter.
Noida Facility Occupancy
91%
Why: Mature facility operating at near-peak capacity.
Total Census Beds
1,750
Why: Stable bed count as the company focuses on ramping up the 700 beds added in Q2.
Average Length of Stay (ALOS)
4.06 days
Why: Reduction driven by introduction of new technologies like robotics and high-end specialties.
Government Revenue Share
35%
Why: Strategic shift to reduce government mix in favor of higher-paying cash and TPA patients.
Trade Receivable Days
115 days
Why: Rigorous collection protocols and better billing processes implemented over the last year.
Doctor Cost % of Revenue
21.5%
Forward-looking targets from management for Q4 FY26
Revenue Growth Target
46%
OPM Guidance
24.5%
Capex Plan
₹1500 Cr
46% Y-o-Y trajectory expected to continue or improve
Consolidated EBITDA margins are guided to be in the 24% to 25% range during the growth phase.
₹1,500 crores
Expansion to 5,000 beds through a mix of greenfield, brownfield, and asset-light models.
Targeting 50% occupancy in new hospitals in the coming quarters.
Guidance Changes
Bed Capacity Target: 3,000 beds by 2028 → 5,000 beds
Revenue, profit and margin growth rates
| Metric | YoY | 3Y CAGR | Trend |
|---|---|---|---|
| Revenue | +46% | +32% | Stable |
| PAT (Net Profit) | +43% | +44% | Stable |
| OPM | 23.0% | -200 bps | Stable |
The above analysis is parsed from publicly available earnings call transcripts. This is educational research only — not investment advice. Last updated Apr 18, 2026.
Based on publicly available financial data. This is educational research, not investment advice.
Yatharth Hospital & Trauma Care Services Ltd's latest quarterly results (Dec 2025) show
Yatharth Hospital & Trauma Care Services Ltd's profit is growing with an stable trend.
Yatharth Hospital & Trauma Care Services Ltd's revenue growth trend is stable.
Yatharth Hospital & Trauma Care Services Ltd's operating margin is stable.
Yatharth Hospital & Trauma Care Services Ltd's long-term compounding rates
Yatharth Hospital & Trauma Care Services Ltd's earnings growth is stable with mixed signals on a sequential basis.
Yatharth Hospital & Trauma Care Services Ltd's trailing twelve month (TTM) performance
Yatharth Hospital & Trauma Care Services Ltd appears slightly undervalued based on our fair value analysis.
Yatharth Hospital & Trauma Care Services Ltd's current PE ratio is 49.6x.
Yatharth Hospital & Trauma Care Services Ltd's current PE is 49.6x.
Yatharth Hospital & Trauma Care Services Ltd's price-to-book ratio is 4.9x.
Yatharth Hospital & Trauma Care Services Ltd is rated Average with a fundamental score of 43.94/100. This score is calculated from objective financial metrics
Yatharth Hospital & Trauma Care Services Ltd has a debt-to-equity ratio of N/A.
Yatharth Hospital & Trauma Care Services Ltd's return ratios over recent years
Yatharth Hospital & Trauma Care Services Ltd's operating cash flow is positive (FY2025).
Yatharth Hospital & Trauma Care Services Ltd currently does not pay a significant dividend (yield 0.00%).
Yatharth Hospital & Trauma Care Services Ltd's shareholding pattern (Mar 2026)
Yatharth Hospital & Trauma Care Services Ltd's promoter holding has remained stable recently.
Yatharth Hospital & Trauma Care Services Ltd has been outperforming Nifty 500 for 5 consecutive weeks, indicating building momentum.
Yatharth Hospital & Trauma Care Services Ltd is an established outperformer with 5 weeks of consecutive Nifty 500 outperformance.
Yatharth Hospital & Trauma Care Services Ltd has 5 key growth catalysts identified from recent earnings analysis
Yatharth Hospital & Trauma Care Services Ltd has 2 key risks worth monitoring
In Q3 FY26, Yatharth Hospital & Trauma Care Services Ltd's management highlighted
Yatharth Hospital & Trauma Care Services Ltd's management has provided the following forward guidance for Q4 FY26
Yatharth Hospital & Trauma Care Services Ltd's most important sub-sector-specific KPIs from the latest concall
Based on quantitative research signals, here is why Yatharth Hospital & Trauma Care Services Ltd may be worth studying
Yatharth Hospital & Trauma Care Services Ltd investment thesis summary:
Yatharth Hospital & Trauma Care Services Ltd's forward outlook based on current data signals
The above FAQs are generated from publicly available earnings data and conference call transcripts. This is educational research only. Sector Alpha is not SEBI registered and does not provide investment advice.
